药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brinzolamide
Berotralstat
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Berotralstat.
Brinzolamide
Ivosidenib
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ivosidenib.
Brinzolamide
Dexverapamil
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dexverapamil.
Brinzolamide
Penfluridol
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Penfluridol.
Brinzolamide
Lorcainide
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lorcainide.
Brinzolamide
Bunaftine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bunaftine.
Brinzolamide
Nizofenone
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nizofenone.
Brinzolamide
Otilonium
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Otilonium.
Brinzolamide
Sultopride
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sultopride.
Brinzolamide
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sitafloxacin.
Brinzolamide
Oxatomide
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Oxatomide.
Brinzolamide
Abexinostat
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Abexinostat.
Brinzolamide
Mizolastine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Mizolastine.
Brinzolamide
Ricolinostat
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ricolinostat.
Brinzolamide
Simendan
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Simendan.
Brinzolamide
CUDC-101
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with CUDC-101.
Brinzolamide
Gilteritinib
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gilteritinib.
Brinzolamide
Entinostat
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Entinostat.
Brinzolamide
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Mocetinostat.
Brinzolamide
Amifampridine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Amifampridine.